Thermo Fisher Scientific Completes Acquisition of CorEvitas
Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Accretive to Adjusted Earnings Per Share1 WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the...
Read more









